secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001641172-25-020651
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs closes $3M senior secured convertible notes with warrants at $0.50
--------------------------------------------------------------------------------

- Notes have 20% original issue discount, secured by Company assets, not convertible for first 4 months.
- Investors also receive warrants exercisable at $0.50 per share; up to $3M additional notes available.
- Proceeds for working capital, general corporate purposes, and repayment of certain existing debt.
- CEO cites potential near-term liquidity events: up to $50M COVID AR collection and possible Nebula Genomics sale.
- Company exploring reverse merger crypto treasury strategy leveraging Nebula's blockchain expertise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000164117225020651/0001641172-25-020651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000164117225020651/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer